ACADIA PHARMACEUTICALS INC (ACAD) insider trading

By person

14 insiders · 1 transaction

0.3×

Catherine Owen holds only 0.3 times base salary in stock. $309.09K of shares against $930.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Catherine Owen last reported holding, valued at $20.88, the price Common Stock was last bought or sold at on the open market here, on 30 Oct 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Mark C. Schneyer

EVP, Chief Financial Officer

—

$69.34K (1)

−$69.34K

71,322

0.0414%

$1.49M

+51.4%

Baker Bros. Advisors LP entity

Director

—

39,384,587

22.86%

$822.35M

+0.2%

Brendan Teehan

EVP, COO, Head of Commercial

—

62,105

0.0360%

$1.30M

+18.1%

Daniel B Soland

Director

—

44,041

0.0256%

$919.58K

+27.1%

Edmund Harrigan

Director

—

43,148

0.0250%

$900.93K

+68.2%

Elizabeth A. Garofalo

Director

—

33,489

0.0194%

$699.25K

+48.7%

Adora Ndu

Director

—

32,908

0.0191%

$687.12K

+113.5%

Laura Brege

Director

—

23,202

0.0135%

$484.46K

+15.1%

Elizabeth H.Z. Thompson

EVP, Head of Research & Dev

—

18,994

0.0110%

$396.59K

—

Adams Catherine Owen

Chief Executive Officer

—

14,803

0.0086%

$309.09K

+404.4%

James Kihara

Principal Accounting Officer

—

13,088

0.0076%

$273.28K

−29.1%

James M Daly

Director

—

12,148

0.0071%

$253.65K

−50.7%

Jennifer J Rhodes

EVP, Chief Legal Officer, Sec

—

11,280

0.0065%

$235.53K

+598.5%

Jonathan Poole

Director

—

2,010

0.0012%

$41.97K

—

ACADIA PHARMACEUTICALS INC

What the insiders did Net selling

By person